News & Events News Discover the latest breakthroughs, stories, and updates from Oncode Institute’s mission to outsmart cancer. Search Category Categorypress newsResearch news AI technology helps to identify brain tumor type during surgery 11 Oct 2023 Hello Bio announces the launch of a novel cutting-edge range of adenosine receptor probes for cancer & cardiovascular research 27 Sep 2023 Start of Oncode Accelerator: patients at the center of innovative cancer drug development 7 Sep 2023 In memoriam – Erica van Wuijtswinkel 7 Sep 2023 Fatty finding fuels scientists’ understanding of human cells 30 Aug 2023 Jan Paul Medema appointed new Scientific Director and Head of Oncode Institute 30 Aug 2023 More accurate understanding of single-cell DNA change 29 Aug 2023 Application of base editors in organoids opens new doors for cancer research 25 Aug 2023 Simmunext Biotherapeutics BV receives further funding 9 Aug 2023 Improving and innovating immunotherapy: Veni grants stimulate innovative research 3 Aug 2023 Oncode Institute enters into an agreement for a clinical proof-of-concept study for tasquinimod in myelofibrosis (MF) 1 Aug 2023 Samen van kanker een behandelbare ziekte maken 19 Jul 2023 Oncode Investigator Anastassis Perrakis elected member of EMBO 5 Jul 2023 Oncode Investigator Miao-Ping Chien and SkylineDx to start TKI-LSH PPP Allowance funded project 27 Jun 2023 Oncode Institute Annual Progress Report now online 26 Jun 2023 Detailed map of childhood soft tissue tumor paves the way for more tailored treatment 22 Jun 2023 Pagination Previous page ‹ … Page 2 Page 3 Page 4 Page 5 Current page 6 Page 7 Page 8 Page 9 Page 10 … Next page ›
Hello Bio announces the launch of a novel cutting-edge range of adenosine receptor probes for cancer & cardiovascular research 27 Sep 2023
Oncode Institute enters into an agreement for a clinical proof-of-concept study for tasquinimod in myelofibrosis (MF) 1 Aug 2023
Oncode Investigator Miao-Ping Chien and SkylineDx to start TKI-LSH PPP Allowance funded project 27 Jun 2023
